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Abstract
Several national studies have shown 
poor compliance with National Cholesterol 
Education Program II (NCEP) goals. A 
study we conducted of patients in the 
General Internal Medicine Clinic at the 
Marshall University Joan C. Edwards 
School of Medicine in Huntington showed 
that 46% of them were not at NCEP goals. 
We hypothesized that both patient and 
physician barriers were responsible for 
these fi ndings so we administered two 
surveys about barriers to cholesterol 
management to 261 random patients 
identifi ed with hypercholesterolemia and 
to all 50 residents and faculty at the clinic. 
We identifi ed insuffi cient knowledge of 
low cholesterol foods as a patient barrier 
(31.6% of patients), and inadequate time 
to review NCEP guidelines as a physician 
barrier (45.5% of physicians). We conclude 
that many patients in our practice lack the 
knowledge of what foods are low in 
cholesterol and that our physicians may 
not use the NCEP guidelines because 
they are inconvenient to access in our 
clinic. Future research should explore 
ways to improve patient knowledge of low 
cholesterol foods and accessibility of 
guidelines for use during patient visits. 
Physician and Patient Barriers to Adherence With 
Cholesterol Guidelines  
Scientific Article
Introduction
Studies have shown poor 
compliance with National Cholesterol 
Education Program (NCEP) guidelines 
(1-6). In the General Internal Medicine 
Clinic at Marshall University Joan C. 
Edwards School of Medicine, a chart 
review revealed that only one-half of 
our patients with hyperlipidemia were 
at the NCEP goal for low-density 
lipoprotein cholesterol (7). Furthermore, 
physicians in our study missed one-half 
of the opportunities to adjust 
cholesterol management based on lipid 
profi les. Although there is a body of 
literature on barriers to physician 
compliance with published guidelines 
(8-10), little data exist on patient 
barriers to cholesterol management 
(11). We hypothesize that patients fail 
to reach NCEP goals because of patient 
and physician barriers. Therefore, we 
surveyed patients and physicians in our 
academic general internal medicine 
practice to identify potential barriers to 
cholesterol management.
Methods
 
We surveyed 300 General Internal 
Medicine patients from our academic 
practice randomly selected from among 
those patients with an ICD-9 code of 
272.0, 272.1, 272.2, 272.3, and 272.4 
who received medical care between 
July 1996 and June 1998. This cohort 
of patients was used in our previous 
research on compliance with NCEP 
guidelines (7). Thirty-nine patients 
were excluded from analysis because 
of incorrect address or death of the 
patient, leaving an available sample 
size of 261. Our study was approved 
by the Marshall University Institutional 
Review Board. 
Survey Development
Based on a review of the literature 
for barriers to compliance with 
cholesterol management guidelines, 
we developed two short surveys each 
each requiring about fi ve minutes to 
complete. We tested the patient survey 
with lay staff for face validity and the 
physician survey with graduating 
residents who were not included in 
this study. All surveys were coded to 
ensure confi dentiality.
The patient survey had fi ve 
questions regarding knowledge and 
attitudes about high cholesterol, low fat 
diet, lipid lowering medication and 
bloodwork. Two questions had 5 point 
Likert scale answers from strongly 
agree to strongly disagree. Three 
questions were multiple choice with 
more than one possible selected 
answer. Patients were mailed the 
survey twice in the spring of 2001 and 
non-responders were contacted by 
phone to obtain a 60.5% response rate. 
Thirty-three of 50 (66%) resident 
and faculty physicians in our General 
Internal Medicine Clinic completed 
the survey concerning barriers to 
cholesterol management. The survey 
comprised eight questions requiring 
5 point Likert scale answers from 
strongly agree to strongly disagree.  
Questions included knowledge of and 
agreement with NCEP guidelines, 
barriers of time to check guidelines 
and time to counsel patients about 
cholesterol, attitude about the 
importance of cholesterol to their 
patients’ health and comfort using 
medications to control cholesterol.  
For data analysis, we combined the 
strongly agree and agree responses into 
one category and similarly combined 
strongly disagree and disagree 
responses. Baseline variables were 
compared by the Student’s t test for 
continuous variables and chi square for 
categorical variables. Simple statistics 
were used to assess responses to the 
survey questions. Multiple logistic 
regression analysis was used to assess 
any affect of patient age, gender, or 
insurance type on responses to the 
survey. All analyses were performed 
using Stata 7.0 statistical software 
(College Station, TX).  
Bayer pharmaceuticals provided a 
grant to conduct the study; however, 
Bayer had no input into the study 
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Table 1. Patient Barriers  — Knowledge.design, collection, analysis and 
interpretation of data, writing of the 
report or in the decision to submit the 
report for publication. The authors had 
full access to all of the data in the study 
and accept full responsibility for the 
integrity of the data and the accuracy of 
the data analysis.
Results
The 158 patients who responded to 
the survey comprised 40.5% males and 
59.5% females with an average age of 
59 years (range 30-86). The most frequent 
insurance coverage of responders was 
Medicare or commercial insurance 
(41.8% Medicare, 41.8% commercial 
insurance, 11.4% Medicaid, and 5% 
self-pay). Non-responders were not 
signifi cantly different in gender (32.3% 
males and 67.7% females), but they 
were somewhat younger with an 
average age of 54 years (range 23-88). 
Non-responders were not signifi cantly 
different compared to responders for 
type of insurance (43.0% commercial 
insurance, 40.9% Medicare, 14.0% 
Medicaid, and 2.1% self-pay). 
Most patients (77.8%) thought they 
knew enough about high cholesterol to 
make a decision about receiving 
treatment and agreed (91.1%) that 
cholesterol was harmful to health 
(Table 1). Patients listed several dietary 
reasons as to why they did not follow a 
cholesterol treatment plan (Table 2), the 
most common being a lack of 
knowledge of low cholesterol foods 
(31.6%).
Only 21 patients (13.3%) reported a 
fear of medication side effects. Even 
though just 14 (8.9%) reported the cost 
of medication as a barrier, cost was a 
problem for 4 of the 8 uninsured patients. 
Nearly one-third of our patients 
reported that their physician did not 
recommend a medication for their 
cholesterol. There was no signifi cant 
difference in the likelihood of being on 
a medication when analyzed by quartiles 
of age. Of the 115 patients taking a 
medication for their cholesterol, 95 
(82.6%) said they take their medication 
regularly. Patients infrequently cited 
barriers related to having bloodwork 
such as diffi culty fasting, transportation, 
cost, and fear of needles. Of these items, 
transportation was the most common 
(5.1%). Using multiple logistic 
regression analysis, we found no 
signifi cant infl uence of age, gender, or 
insurance type on patients’ reponses.  
Table 2. Patient Barriers  — Diet, Medication and Bloodwork.
 Most of our resident and faculty 
physicians are aware of (90.9%) and 
agree with (75.8%) NCEP guidelines 
(Table 3). Fifteen physicians (45.5%) 
reported that they had insuffi cient time 
to review NCEP guidelines during 
patient visits, but most physicians did 
counsel patients about cholesterol 
(87.9%). Seven (21.2%) physicians 
reported cholesterol as the “least of my 
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patients problems.” However, 28 
(84.8%) felt that high cholesterol was 
“important to my patients’ health.” 
Although most physicians (78.8%) agreed 
the benefi ts of using medications to 
lower cholesterol outweighed their 
risks, 9 (27.3%) would hesitate to use a 
combination of drugs to control 
cholesterol.
Discussion
The fact that 91.1% of the patients 
we surveyed know that high cholesterol 
is harmful to their health suggests that 
national and local education efforts to 
improve public awareness of the risk 
of high cholesterol have succeeded. 
Nonetheless, barriers exist in our 
patients’ knowledge of low cholesterol 
foods, a fi nding consistent with another 
survey of patient dietary knowledge by 
Schectman et al (12). 
Although the General Internal 
Medicine Clinic employs a dietician, 
some of the patients may not be able to 
take advantage of this resource or their 
physician may not refer them for dietary 
education. However, the survey by 
Schectman et al (12)  indicated that prior 
knowledge and education level, rather 
than an intervention of physician or 
dietician counseling, were predictive of 
high dietary knowledge scores. Further 
study of educational interventions 
addressing diet is needed to reduce this 
potential barrier to cholesterol 
management.
Patients did not consider medication 
side effects to be a major barrier. The 
answer to that question may be 
different now, since four months after 
we conducted our survey, cerivastatin 
(Baycol) was removed from the U.S. 
market (Aug. 8, 2001) (13). In addition, 
patients did not consider the cost of 
medication as a major barrier, even for 
those patients with Medicare as their 
primary insurance; however, it may be 
a barrier for uninsured patients.  
About one-third of our patients who 
had a diagnosis of hypercholesterolemia 
reported that their physician did not 
recommend drug treatment. Our study 
is limited since it relies on a cohort of 
patients with ICD-9 codes for 
hyperlipidemia in that some of these 
patients may have high total cholesterol 
with a favorable ratio of HDL to LDL 
making them ineligible for drug therapy. 
However, in our previous study of this 
Nine (27.3%) of the physicians 
that we surveyed hesitate to use 
combinations of lipid lowering 
medications. More aggressive 
treatment of hypercholesterolemia 
with high doses of one medication and 
combinations of medications will be 
needed for all patients to reach NCEP 
goals. Multi-drug regimens have 
potential for serious side effects like 
rhabdomyolysis and many physicians 
may hesitate to risk harm with a 
preventive therapy. This barrier may 
be addressed as newer lipid lowering 
medications with fewer and less toxic 
side effects are developed, especially 
for use in combination (15).
Our study was limited by a low 
response rate for both patients and 
physicians. We attempted to improve 
the response rate by calling those 
patients who did not answer the second 
mailing. The addition of telephone 
surveys to the mailed surveys may 
have introduced some bias since the 
investigators called patients directly, 
although it was limited in that the 
physicians were not permitted to 
telephone their own patients. Our 
study is limited also as our patient 
population comprises primarily white 
Appalachians. Other investigators 
treating diverse populations should 
survey their patients about potential 
barriers to cholesterol management 
so that a better overall picture of the 
barriers that exist can be addressed.  
Table 3. Physician Barriers.
same cohort of patients, we found that 
physicians did not aggressively change 
therapy in response to lipid levels that 
persisted above NCEP goals (7). Thus, 
it is likely that many of the patients not 
on medications should be receiving 
drug treatment according to the NCEP 
guidelines. Our fi ndings are in line 
with a study of consumer attitudes on 
cholesterol management which was 
supported by the National Lipid 
Association indicating that physicians 
are conservative in prescribing lipid 
lowering medication. It revealed 51% of 
600 moderate-risk patients reported 
their physicians did not recommend a 
cholesterol lowering medication (14).
Our physicians are generally in 
agreement with the NCEP guidelines; 
only 6.1% reported disagreement. A 
meta-analysis of physician compliance 
with guidelines by Cabana et al found 
on average about 10% disagreement 
with published guidelines (9). 
In addition, our survey showed 
that almost half of our physicians 
complained that the guidelines are 
inconvenient for use during patient 
encounters. Considering that the NCEP 
Adult Treatment Panel III guidelines 
are somewhat more complicated 
than the NCEP II guidelines, this 
barrier is most probably increasing 
in importance. We plan to evaluate 
the benefi t of handheld computer 
programs that make the guidelines 
more accessible.
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Conclusion
The implications of our study 
are that patients may benefi t from 
improved dietary knowledge and 
that physicians need a convenient 
way to access and use the NCEP 
guidelines. Moreover, physicians need 
increased confi dence in prescribing 
combinations of cholesterol medications. 
Interventions which address these 
needs should lead to improved control 
of hypercholesterolemia and ultimately 
a reduction in atherosclerotic disease.
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